Cyanotech reports Q1 results
- BySeeking Alpha-
Cyanotech (CYAN): Q1 GAAP EPS of $0.08.Revenue of $8.96M (+21.9% Y/Y)Press Release
Symbol | Exchange | Currency |
|---|
Cyanotech (CYAN): Q1 GAAP EPS of $0.08.Revenue of $8.96M (+21.9% Y/Y)Press Release
Cyanotech (CYAN): Q4 GAAP EPS of -$0.03.Revenue of $9.44M (+9.4% Y/Y)Shares +1.80% PM.Press Release
It shouldn’t be so surprising now after months of huge moves in the market, but March was another stellar month for my day trading accounts. My net profits for the month came in...
HOURLY CHART2nd July:At long last recent moves have gone in line with my forecasts and this does seem to favour my expectations of the 0.9060-79 area holding. We may have seen the...
What is the Truth of Small-Cap Investing? Small-cap stocks have earned the reputation as the ‘wild card’ of the stock market game. But do these tiny firms deserve the...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Sell | Sell | Strong Sell |
| Technical Indicators | Sell | Sell | Strong Buy | Strong Sell | Neutral |
| Summary | Sell | Neutral | Neutral | Strong Sell | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 146.92 | 147.47 | 145.56 | +0.09 | +0.06% | 53.16M | NASDAQ | |||
| 2,844.30 | 2,846.60 | 2,804.80 | +20.0 | +0.71% | 1.14M | NASDAQ | |||
| 352.96 | 354.35 | 342.37 | +7.00 | +2.02% | 18.74M | NASDAQ | |||
| 43.94 | 44.41 | 43.81 | -0.25 | -0.57% | 16.00M | NYSE | |||
| 149.59 | 151.85 | 148.00 | -9.99 | -6.26% | 26.85M | NYSE | |||
| 15.29 | 15.35 | 15.15 | -0.07 | -0.46% | 330.15K | NASDAQ | |||
| 6.62 | 6.63 | 6.57 | +0.110 | +1.69% | 1.17M | NYSE | |||
| 10.14 | 10.14 | 10.04 | -0.19 | -1.84% | 150.39K | NYSE | |||
| 33.29 | 33.47 | 33.23 | +0.15 | +0.45% | 130.33K | NYSE | |||
| 2,852.70 | 2,858.10 | 2,817.00 | +16.1 | +0.57% | 741.74K | NASDAQ | |||
| 9.35 | 9.49 | 9.00 | +0.21 | +2.30% | 93.97K | NASDAQ | |||
| 28.07 | 28.31 | 27.93 | -0.93 | -3.21% | 13.21K | NYSE | |||
| 6.32 | 6.62 | 5.63 | +0.080 | +1.28% | 44.39M | NASDAQ | |||
| 53.89 | 54.24 | 53.86 | -0.15 | -0.28% | 9.66M | NYSE | |||
| 163.04 | 163.59 | 160.82 | +1.86 | +1.15% | 9.67M | NYSE |
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company's products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health. The Company cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The Company produces its algae in Hawaii and manufactures the finished products in Hawaii and California.